arrow
Z

Zihua Zou

fujian cancer hospital
H指数:7
被引数:152

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intracranial Efficacy of Crizotinib and Postprogression Therapeutic Strategies in Advanced c-ros Oncogene 1 (ROS1)-Positive Non–Small Cell Lung Cancer (NSCLC), a Multicenter Real-World Study

克唑替尼在c-ros原癌基因1(ROS1)阳性晚期非小细胞肺癌(NSCLC)中的颅内疗效及进展后治疗策略:一项多中心真实世界研究

MedComm
IF10.7
2026-07-280
OAAI
Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis
2024-08-050
OAAI
Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer

脑脊液循环肿瘤DNA有助于检测和表征非小细胞肺癌的软脑膜转移

2023-12-162
PRE
Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer
2023-07-013
PRE
Alectinib as first-line treatment for advanced ALK-positive non- small cell lung cancer in the real-world setting: preliminary analysis in a Chinese cohort

阿来替尼作为一线治疗晚期ALK阳性非小细胞肺癌的真实世界: 中国队列的初步分析

2022-12-013
OAAI